Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$6.8M
Filings
31
Firms Hired
2
Active Period
2005–2012
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Safeguarding America's Pharmaceuticals Act of 2011
2012 · third_quarter · Firm: AMYLIN PHARMACEUTICALS
Perscription Drug User Fee Act Reauthorization FDA funding and agency effectiveness Drug importation issues Safeguarding America's Pharmaceuticals Act of 2011- H.R. 3026
Client expense: $170,000 · Firm income: —
Matched citations: H.R. 3026
Safeguarding America's Pharmaceuticals Act of 2011
2012 · second_quarter · Firm: AMYLIN PHARMACEUTICALS
Perscription Drug User Fee Act Reauthorization FDA funding and agency effectiveness Drug importation issues Safeguarding America's Pharmaceuticals Act of 2011- H.R. 3026
Client expense: $260,000 · Firm income: —
Matched citations: H.R. 3026
Safeguarding America's Pharmaceuticals Act of 2011
2012 · first_quarter · Firm: AMYLIN PHARMACEUTICALS
Perscription Drug User Fee Act Reauthorization FDA funding and agency effectiveness Drug importation issues Safeguarding America's Pharmaceuticals Act of 2011- H.R. 3026
Client expense: $340,000 · Firm income: —
Matched citations: H.R. 3026
Safeguarding America's Pharmaceuticals Act of 2011
2011 · fourth_quarter · Firm: AMYLIN PHARMACEUTICALS
Perscription Drug User Fee Act Reauthorization FDA funding and agency effectiveness Drug importation issues Safeguarding America's Pharmaceuticals Act of 2011- H.R. 3026
Client expense: $240,000 · Firm income: —
Matched citations: H.R. 3026
Safeguarding America's Pharmaceuticals Act of 2011
2011 · third_quarter · Firm: AMYLIN PHARMACEUTICALS
Perscription Drug User Fee Act reauthorization FDA funding and agency effectiveness Drug importation issues Safeguarding America's Pharmaceuticals Act of 2011- H.R. 3026
Client expense: $250,000 · Firm income: —
Matched citations: H.R. 3026
Patent Reform Act of 2009
2010 · fourth_quarter · Firm: AMYLIN PHARMACEUTICALS
Exclusivity, damages and estoppel provisions in the Patent Reform Act of 2009 (S. 515, H.R. 1260)
Client expense: $200,000 · Firm income: —
Matched citations: H.R. 1260
Exclusivity, damages and estoppel provisions in the Patent Reform Act of 2009 (S. 515, H.R. 1260)
Client expense: $200,000 · Firm income: —
Matched citations: S. 515
Exclusivity, damages and estoppel provisions in the Patent Reform Act of 2009 (S. 515, H.R. 1260)
Client expense: $200,000 · Firm income: —
Matched citations: H.R. 1260
Exclusivity, damages and estoppel provisions in the Patent Reform Act of 2009 (S. 515, H.R. 1260)
Client expense: $200,000 · Firm income: —
Matched citations: S. 515
Patent Reform Act of 2009
2010 · second_quarter · Firm: AMYLIN PHARMACEUTICALS
Exclusivity, damages and estoppel provisions in the Patent Reform Act of 2009 (S. 515, H.R. 1260)
Client expense: $240,000 · Firm income: —
Matched citations: H.R. 1260
Exclusivity, damages and estoppel provisions in the Patent Reform Act of 2009 (S. 515, H.R. 1260)
Client expense: $240,000 · Firm income: —
Matched citations: S. 515
Exclusivity, damages and estoppel provisions in the Patent Reform Act of 2009 (S. 515, H.R. 1260)
Client expense: $320,000 · Firm income: —
Matched citations: H.R. 1260
Exclusivity, damages and estoppel provisions in the Patent Reform Act of 2009 (S. 515, H.R. 1260)
Client expense: $320,000 · Firm income: —
Matched citations: S. 515
American Middle Class Tax (AMT) Relief Act of 2007
2009 · fourth_quarter · Firm: AMYLIN PHARMACEUTICALS
Provisions related to the expansion of Medicaid rebates in the Affordable Health Care for America Act (H.R. 3962)- House and the Patient Protection and Affordable Care Act (H.R. 3590)-Senate Provisions related to the expansion of Medicaid eligibility in the Affordable Health Care for America Act (H.R. 3962)- House and the Patient Protection and Affordable Care Act (H.R. 3590)-Senate Provisions related to Medicare Part D in the Affordable Health Care for America Act (H.R. 3962)- House and the Patient Protection and Affordable Care Act (H.R. 3590)-Senate
Client expense: $290,000 · Firm income: —
Matched citations: H.R. 3590
American Middle Class Tax (AMT) Relief Act of 2007
2009 · fourth_quarter · Firm: AMYLIN PHARMACEUTICALS
Provisions related to comparative effectiveness reserach in the Affordable Health Care for America Act (H.R. 3962)- House and the Patient Protection and Affordable Care Act (H.R. 3590)-Senate
Client expense: $290,000 · Firm income: —
Matched citations: H.R. 3590
American Middle Class Tax (AMT) Relief Act of 2007
2009 · fourth_quarter · Firm: AMYLIN PHARMACEUTICALS
Physician Payments Sunshine provision of H.R. 3200 America's Affordable Health Choices Act of 2009 Physician Payments Sunshine provision of Affordable Health Care for America Act (H.R. 3962)- House Physician Payments Sunshine provision of Patient Protection and Affordable Care Act (H.R. 3590)-Senate FDA Risk Evaulation Mitigation Strategies (REMS) Drug Safety Communications Drug importation issues in the Affordable Health Care for America Act (H.R. 3962)- House and the Patient Protection and Affordable Care Act (H.R. 3590)-Senate
Client expense: $290,000 · Firm income: —
Matched citations: H.R. 3590
American Middle Class Tax (AMT) Relief Act of 2007
2009 · fourth_quarter · Firm: AMYLIN PHARMACEUTICALS
Chronic disease and diabetes care related provisions in Affordable Health Care for America Act (H.R. 3962)- House and the Patient Protection and Affordable Care Act (H.R. 3590)-Senate Provisions related to comparative effectiveness reserach and reimbursement in the Affordable Health Care for America Act (H.R. 3962)- House and the Patient Protection and Affordable Care Act (H.R. 3590)-Senate
Client expense: $290,000 · Firm income: —
Matched citations: H.R. 3590
Superfund Polluter Pays Act
2009 · fourth_quarter · Firm: AMYLIN PHARMACEUTICALS
Provisions related to comparative effectiveness reserach in the Affordable Health Care for America Act (H.R. 3962)- House and the Patient Protection and Affordable Care Act (H.R. 3590)-Senate
Client expense: $290,000 · Firm income: —
Matched citations: H.R. 3962
Superfund Polluter Pays Act
2009 · fourth_quarter · Firm: AMYLIN PHARMACEUTICALS
Physician Payments Sunshine provision of H.R. 3200 America's Affordable Health Choices Act of 2009 Physician Payments Sunshine provision of Affordable Health Care for America Act (H.R. 3962)- House Physician Payments Sunshine provision of Patient Protection and Affordable Care Act (H.R. 3590)-Senate FDA Risk Evaulation Mitigation Strategies (REMS) Drug Safety Communications Drug importation issues in the Affordable Health Care for America Act (H.R. 3962)- House and the Patient Protection and Affordable Care Act (H.R. 3590)-Senate
Client expense: $290,000 · Firm income: —
Matched citations: H.R. 3962
Superfund Polluter Pays Act
2009 · fourth_quarter · Firm: AMYLIN PHARMACEUTICALS
Provisions related to the expansion of Medicaid rebates in the Affordable Health Care for America Act (H.R. 3962)- House and the Patient Protection and Affordable Care Act (H.R. 3590)-Senate Provisions related to the expansion of Medicaid eligibility in the Affordable Health Care for America Act (H.R. 3962)- House and the Patient Protection and Affordable Care Act (H.R. 3590)-Senate Provisions related to Medicare Part D in the Affordable Health Care for America Act (H.R. 3962)- House and the Patient Protection and Affordable Care Act (H.R. 3590)-Senate
Client expense: $290,000 · Firm income: —
Matched citations: H.R. 3962
Superfund Polluter Pays Act
2009 · fourth_quarter · Firm: AMYLIN PHARMACEUTICALS
Chronic disease and diabetes care related provisions in Affordable Health Care for America Act (H.R. 3962)- House and the Patient Protection and Affordable Care Act (H.R. 3590)-Senate Provisions related to comparative effectiveness reserach and reimbursement in the Affordable Health Care for America Act (H.R. 3962)- House and the Patient Protection and Affordable Care Act (H.R. 3590)-Senate
Client expense: $290,000 · Firm income: —
Matched citations: H.R. 3962
Patent Reform Act of 2009
2009 · fourth_quarter · Firm: AMYLIN PHARMACEUTICALS
Exclusivity, damanges and estoppel provisions in the Patent Reform Act of 2009 (S. 515, H.R. 1260)
Client expense: $290,000 · Firm income: —
Matched citations: H.R. 1260
America's Affordable Health Choices Act of 2009
2009 · fourth_quarter · Firm: AMYLIN PHARMACEUTICALS
Physician Payments Sunshine provision of H.R. 3200 America's Affordable Health Choices Act of 2009 Physician Payments Sunshine provision of Affordable Health Care for America Act (H.R. 3962)- House Physician Payments Sunshine provision of Patient Protection and Affordable Care Act (H.R. 3590)-Senate FDA Risk Evaulation Mitigation Strategies (REMS) Drug Safety Communications Drug importation issues in the Affordable Health Care for America Act (H.R. 3962)- House and the Patient Protection and Affordable Care Act (H.R. 3590)-Senate
Client expense: $290,000 · Firm income: —
Matched citations: H.R. 3200
Exclusivity, damanges and estoppel provisions in the Patent Reform Act of 2009 (S. 515, H.R. 1260)
Client expense: $290,000 · Firm income: —
Matched citations: S. 515
Exclusivity, and damanges provisions in the Patent Reform Act of 2009 (S. 515, H.R. 1260)
Client expense: $290,000 · Firm income: —
Matched citations: H.R. 1260
Source: Senate LDA